Ascendis Pharma AS (A71) — Tangible Net Worth Ratio
Ascendis Pharma AS (A71) has a Tangible Net Worth Ratio of 100.0% as of March 2026. This metric is calculated by deducting intangible assets (€0.00) from net assets (€487.97 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See working capital to net assets of Ascendis Pharma AS to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Ascendis Pharma AS Tangible Net Worth Ratio (2016–2022)
This chart shows how Ascendis Pharma AS's Tangible Net Worth Ratio has changed across 7 annual periods from 2016 to 2022. As of March 2026, the ratio stands at 100.0%, reflecting net assets of €487.97 Million with intangible assets of €0.00 EUR. See operational self-sufficiency of Ascendis Pharma AS to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Ascendis Pharma AS (2016–2022)
The table below presents the year-by-year Tangible Net Worth Ratio for Ascendis Pharma AS from 2016 to 2022, covering 7 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see A71 company net worth.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2022 | 99.5% | €263.35 Million | €1.33 Million | €1.09 Billion | ▼ -0.3 pp |
| 2021 | 99.8% | €883.63 Million | €1.78 Million | €1.08 Billion | ▲ +0.1 pp |
| 2020 | 99.7% | €838.71 Million | €2.22 Million | €979.79 Million | ▼ -0.3 pp |
| 2019 | 100.0% | €597.11 Million | €0.00 | €676.73 Million | ▲ +0.0 pp |
| 2018 | 100.0% | €280.05 Million | €0.00 | €318.97 Million | ▲ +1.9 pp |
| 2017 | 98.1% | €187.21 Million | €3.50 Million | €210.98 Million | ▼ -1.9 pp |
| 2016 | 100.0% | €176.61 Million | €0.00 | €190.07 Million | — |